Balaglitazone

Balaglitazone

CAT N°: 28866
Price:

182.00 154.70

Balaglitazone is a partial agonist of peroxisome proliferator-activated receptor ? (PPAR?; EC50 = 1.351 ?M in a transactivation assay).{48619} It decreases non-fasting plasma glucose levels in diabetic db/db mice (ED90 = 3 mg/kg per day). Balaglitazone (5 and 10 mg/kg per day) decreases plasma levels of insulin and glucose in an oral glucose tolerance test in diet-induced obese rats.{48620} In doxorubicin-resistant K562 human myelogenous leukemia cells, balaglitazone (25 ?M) decreases P-glycoprotein (P-gp) levels, increases intracellular accumulation of the P-gp substrate rhodamine 123 (Item No. 16672), and sensitizes cells to doxorubicin (Item No. 15007).{48621}

We also advise you